The FDA has a new commissioner and policies have changed. Everyone has heard about fewer regulations and the FDA moving to a more cooperative stance. But that doesn’t mean that inspections will stop.
The investigators are still out there… still inspecting drug and medical device manufacturers every day.
You can’t afford to be complacent. Now is not the time to be caught off guard.
Mark your calendar and book reservations now for the event of the year for every FDA-regulated drug, biologics and device maker — the 12th Annual FDA Inspections Summit.
Over three days of discovery and networking, you’ll get an inside look into what the current administration has in store for you.
You’ll hear top FDAers reveal changes they intend to make ... engage with inspectors as they make ready to march to different drummers ... learn from the lawyers, consultants and wise-men-and-women who devote their professional lives to guiding and protecting FDA-regulated clients like you ... and hear the stories of industry colleagues who’ve mastered compliance at the cutting edge.
Arrive a day early for side-by-side pre-conference workshops filled with tips and tricks to help you pass your next inspection with flying colors. One workshop is for drugmakers, the other for devicemakers.
The Summit Conference takes place at the recently renovated Doubletree Bethesda Hotel, equidistant between FDA headquarters and the attractions of the Nation’s Capital. You’re just a few blocks from Washington’s Metro subway, plus scads of top-rated restaurants and watering holes in Bethesda’s picturesque Woodmont Triangle.
And here’s a tip not everyone knows: The Washington area is breathtaking in early November — trees bursting with fall colors, mild days, cool nights. Stay the weekend if you can.
With new leadership at the FDA, change is in the air. You need to get ahead of it — for the sake of your products, your people, your customers and your clients. Don’t miss this once-a-year opportunity to gain priceless regulatory knowledge and insights.
Testimonials From Past Attendees:
– Dan Lewis, Site Quality Leader, P&G
– Nancy Carranza, Vice President, Operations, GSMS, Inc.
– Johanna Stamates, Executive Director - Research Compliance
and Quality Assurance, University of Miami
– Thomas Hoffman, Compliance, Medtronic